These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38123765)

  • 41. Metallic microneedles with interconnected porosity: A scalable platform for biosensing and drug delivery.
    Cahill EM; Keaveney S; Stuettgen V; Eberts P; Ramos-Luna P; Zhang N; Dangol M; O'Cearbhaill ED
    Acta Biomater; 2018 Oct; 80():401-411. PubMed ID: 30201432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in microneedle-based transdermal delivery for drugs and peptides.
    Aich K; Singh T; Dang S
    Drug Deliv Transl Res; 2022 Jul; 12(7):1556-1568. PubMed ID: 34564827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conductive Microneedle Patch with Electricity-Triggered Drug Release Performance for Atopic Dermatitis Treatment.
    Yang Y; Chen BZ; Zhang XP; Zheng H; Li Z; Zhang CY; Guo XD
    ACS Appl Mater Interfaces; 2022 Jul; 14(28):31645-31654. PubMed ID: 35790212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.
    McCrudden MT; Alkilani AZ; McCrudden CM; McAlister E; McCarthy HO; Woolfson AD; Donnelly RF
    J Control Release; 2014 Apr; 180(100):71-80. PubMed ID: 24556420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
    Cahill EM; O'Cearbhaill ED
    Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transdermal electroosmotic flow generated by a porous microneedle array patch.
    Kusama S; Sato K; Matsui Y; Kimura N; Abe H; Yoshida S; Nishizawa M
    Nat Commun; 2021 Jan; 12(1):658. PubMed ID: 33510169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays.
    Allen LV
    Int J Pharm Compd; 2023; 27(1):30-37. PubMed ID: 36720061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of microneedles shape on skin penetration and transdermal drug administration.
    De Martino S; Battisti M; Napolitano F; Palladino A; Serpico L; Amendola E; Martone A; De Girolamo P; Squillace A; Dardano P; De Stefano L; Dello Iacono S
    Biomater Adv; 2022 Nov; 142():213169. PubMed ID: 36302329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design of three-section microneedle towards low insertion force and high drug delivery amount using the finite element method.
    Zhang L; Zhu C; Shi J; Zhou Z; Ge D
    Comput Methods Biomech Biomed Engin; 2024; 27(2):156-166. PubMed ID: 36762916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of microneedles and microchannels for enhanced transdermal drug delivery.
    Puri A; Nguyen HX; Tijani AO; Banga AK
    Ther Deliv; 2021 Jan; 12(1):77-103. PubMed ID: 33410340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanomaterial and advanced technologies in transdermal drug delivery.
    Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
    J Drug Target; 2020 Apr; 28(4):356-367. PubMed ID: 31851847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
    Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
    Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Individually coated microneedles for co-delivery of multiple compounds with different properties.
    Li S; Li W; Prausnitz M
    Drug Deliv Transl Res; 2018 Oct; 8(5):1043-1052. PubMed ID: 29948917
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Li S; Cao S; Lu H; He B; Gao B
    Mater Today Bio; 2024 Jun; 26():101044. PubMed ID: 38600920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations.
    Kirkby M; Hutton ARJ; Donnelly RF
    Pharm Res; 2020 Jun; 37(6):117. PubMed ID: 32488611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
    Donnelly RF; Garland MJ; Alkilani AZ
    Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement strategies for transdermal drug delivery systems: current trends and applications.
    Ramadon D; McCrudden MTC; Courtenay AJ; Donnelly RF
    Drug Deliv Transl Res; 2022 Apr; 12(4):758-791. PubMed ID: 33474709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging trends in microneedle-based drug delivery strategies for the treatment of rheumatoid arthritis.
    Gorantla S; Batra U; Puppala ER; Waghule T; Naidu VGM; Singhvi G
    Expert Opin Drug Deliv; 2022 Apr; 19(4):395-407. PubMed ID: 35287532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of microneedles for drug and vaccine delivery.
    Quinn HL; Kearney MC; Courtenay AJ; McCrudden MT; Donnelly RF
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1769-80. PubMed ID: 25020088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microneedles as transdermal delivery systems: combination with other enhancing strategies.
    Nava-Arzaluz MG; Calderon-Lojero I; Quintanar-Guerrero D; Villalobos-Garcia R; Ganem-Quintanar A
    Curr Drug Deliv; 2012 Jan; 9(1):57-73. PubMed ID: 21864254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.